Vor Bio (VOR) announced the appointment of Adi Osovsky, S.J.D. as General Counsel. Dr. Osovsky brings 17 years of corporate counsel and law firm experience in the biotechnology and pharmaceutical sectors. Dr. Osovsky joins Vor Bio from iTeos Therapeutics (ITOS), where she served as Executive Vice President, Head of Legal & Corporate Secretary.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VOR:
- Vor Biopharma Appoints Sarah Reed to Board
- Vor Biopharma Files Prospectus for $119.7M Stock Sale
- Vor Bio’s telitacicept achieved primary endpoint in Phase 3 study
- Largest borrow rate increases among liquid names
- Positive Phase 3 Results and Strong Financial Position Support Buy Rating for Vor Biopharma